Switch theme
Sign up to access all valuation multiples
Deepnoid Inc is a doctor-driven medical AI platform. It is an open platform that supports doctor-led medical imaging AI model research efficiently. It uses both the image processing module and neural network module provided by default for free, and can effectively use computing resources in the form of a cloud.
2008
n/a
LTM Revenue $10.6M
LTM EBITDA $0.7M
$98.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Deepnoid has a last 12-month revenue (LTM) of $10.6M and a last 12-month EBITDA of $0.7M.
In the most recent fiscal year, Deepnoid achieved revenue of $7.9M and an EBITDA of -$5.9M.
Deepnoid expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Deepnoid valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $10.6M | XXX | $7.9M | XXX | XXX | XXX |
| Gross Profit | $3.1M | XXX | $0.8M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 10% | XXX | XXX | XXX |
| EBITDA | $0.7M | XXX | -$5.9M | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | -74% | XXX | XXX | XXX |
| EBIT | -$4.7M | XXX | -$7.3M | XXX | XXX | XXX |
| EBIT Margin | -44% | XXX | -93% | XXX | XXX | XXX |
| Net Profit | -$4.4M | XXX | -$6.6M | XXX | XXX | XXX |
| Net Margin | -41% | XXX | -84% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Deepnoid's stock price is KRW 6170 (or $4).
Deepnoid has current market cap of KRW 138B (or $101M), and EV of KRW 135B (or $98.5M).
See Deepnoid trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $98.5M | $101M | XXX | XXX | XXX | XXX | $-0.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Deepnoid has market cap of $101M and EV of $98.5M.
Deepnoid's trades at 12.5x EV/Revenue multiple, and -16.8x EV/EBITDA.
Equity research analysts estimate Deepnoid's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Deepnoid has a P/E ratio of -23.1x.
See valuation multiples for Deepnoid and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $101M | XXX | $101M | XXX | XXX | XXX |
| EV (current) | $98.5M | XXX | $98.5M | XXX | XXX | XXX |
| EV/Revenue | 9.3x | XXX | 12.5x | XXX | XXX | XXX |
| EV/EBITDA | 150.1x | XXX | -16.8x | XXX | XXX | XXX |
| EV/EBIT | -20.9x | XXX | -13.4x | XXX | XXX | XXX |
| EV/Gross Profit | 32.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -23.1x | XXX | -15.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -5.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDeepnoid's last 12 month revenue growth is 60%
Deepnoid's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Deepnoid's rule of 40 is -249% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Deepnoid's rule of X is 157% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Deepnoid and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 60% | XXX | 63% | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | -74% | XXX | XXX | XXX |
| EBITDA Growth | 1488% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -249% | XXX | -14% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 157% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 22% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 103% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Deepnoid acquired XXX companies to date.
Last acquisition by Deepnoid was XXXXXXXX, XXXXX XXXXX XXXXXX . Deepnoid acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Deepnoid founded? | Deepnoid was founded in 2008. |
| Where is Deepnoid headquartered? | Deepnoid is headquartered in South Korea. |
| Is Deepnoid publicy listed? | Yes, Deepnoid is a public company listed on KRX. |
| What is the stock symbol of Deepnoid? | Deepnoid trades under 315640 ticker. |
| When did Deepnoid go public? | Deepnoid went public in 2021. |
| Who are competitors of Deepnoid? | Similar companies to Deepnoid include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Deepnoid? | Deepnoid's current market cap is $101M |
| What is the current revenue of Deepnoid? | Deepnoid's last 12 months revenue is $10.6M. |
| What is the current revenue growth of Deepnoid? | Deepnoid revenue growth (NTM/LTM) is 60%. |
| What is the current EV/Revenue multiple of Deepnoid? | Current revenue multiple of Deepnoid is 9.3x. |
| Is Deepnoid profitable? | Yes, Deepnoid is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Deepnoid? | Deepnoid's last 12 months EBITDA is $0.7M. |
| What is Deepnoid's EBITDA margin? | Deepnoid's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of Deepnoid? | Current EBITDA multiple of Deepnoid is 150.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
